Product Dossier
LUTATHERA
Product Dossier for LUTATHERA (lutetium (177Lu) oxodotreotide, Novartis Pharmaceuticals). ARTG record, PBS listing, PBAC outcomes, AusPAR — compiled by…
- Sponsor: Novartis Pharmaceuticals
- Active ingredient: lutetium (177Lu) oxodotreotide
- Therapeutic area: Oncology
- Same area: TALZENNA
- Same area: ZARZIO